Literature DB >> 15167009

Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma.

José Antonio López-Guerrero1, Concha López-Ginés, Antonio Pellín, Carmen Carda, Antonio Llombart-Bosch.   

Abstract

Osteosarcoma (OS) displays complex karyotypes with numerical changes as well as structural abnormalities suggesting that several oncogenes and tumor suppressor genes may be implicated in the biology of OS. The aim of our study was to investigate the possible implication of the molecular alterations of the G1 to S-phase checkpoint genes in the pathogenesis of OS. We analyzed samples from 29 patients and found molecular alterations of the RB and TP53 genes in 6 (21%) and 3 (10%) cases, respectively. Homozygous deletion of the INK4A/ARF locus and methylation of INK4A was detected in 3 (10%) and 2 (7%) cases, respectively. CDK4 and MDM2 co-amplification was observed in 1 case (3%). Cyclin D3 is differentially expressed in a greater proportion than D1- and D2-type cyclins. Cytogenetically, all cases had complex karyotypes being especially significant the losses of the chromosomes 4, 13, and 17. As a whole, 11 of 29 (38%) analyzed OS presented alterations in some of the analyzed G1 to S-phase checkpoint genes. These alterations were more frequently present in adults (P = 0.032). All patients with genetic alterations in the G1/S-phase checkpoint died during their clinical follow-up, whereas more than 53% of the remaining cases were alive in this period (P = 0.007). Hence, in the pathogenesis of human OS, deregulation of the G1/S checkpoint genes, especially RB, TP53, and INK4/ARF locus, plays an important role and defines a subgroup of patients with a poor outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15167009     DOI: 10.1097/00019606-200406000-00004

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  14 in total

1.  Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell.

Authors:  Ting Wang; Xia Gong; Rong Jiang; Hongzhong Li; Weimin Du; Ge Kuang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.

Authors:  Silvia Calabuig-Fariñas; Rosario Gil Benso; Karoly Szuhai; Isidro Machado; José Antonio López-Guerrero; Danielle de Jong; Amando Peydró; Teresa San Miguel; Lara Navarro; Antonio Pellín; Antonio Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2012-02-15       Impact factor: 3.201

Review 3.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

4.  Integrative metabolome and transcriptome profiling reveals discordant glycolysis process between osteosarcoma and normal osteoblastic cells.

Authors:  Kai Chen; Chunyan Zhu; Ming Cai; Dong Fu; Biao Cheng; Zhengdong Cai; Guodong Li; Jilong Liu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-12       Impact factor: 4.553

Review 5.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

6.  Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.

Authors:  Jaime F Modiano; Matthew Breen; Rachael Thomas; Huixia J Wang; Pei-Chien Tsai; Cordelia F Langford; Susan P Fosmire; Cristan M Jubala; David M Getzy; Gary R Cutter
Journal:  Chromosome Res       Date:  2009-04-01       Impact factor: 5.239

7.  Circulating tumour-derived DNA in metastatic soft tissue sarcoma.

Authors:  Nicholas C Eastley; Barbara Ottolini; Rita Neumann; Jin-Li Luo; Robert K Hastings; Imran Khan; David A Moore; Claire P Esler; Jacqueline A Shaw; Nicola J Royle; Robert U Ashford
Journal:  Oncotarget       Date:  2018-01-19

8.  RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells.

Authors:  T Yan; G Tang; T Ren; D Shen; K Sun; W Liang; W Guo
Journal:  Cancer Gene Ther       Date:  2011-03-25       Impact factor: 5.987

9.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

10.  Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation.

Authors:  Khaldoun Al-Romaih; Gino R Somers; Jane Bayani; Simon Hughes; Mona Prasad; Jean-Claude Cutz; Hui Xue; Maria Zielenska; Yuzhuo Wang; Jeremy A Squire
Journal:  Cancer Cell Int       Date:  2007-09-10       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.